Skip to content

Ongoing challenges in providing PMTCT in Kenya and Malawi

Long-term immune response to vaccines is impaired in people with HIV

Health systems, not family factors, most crucial in PMTCT outcomes, Kenyan study shows

Only a fifth of pregnancies among women living with HIV in the US are planned

Microbicide ring study shows users are reassured about discomfort but develop new worries about safety

A silicone vaginal ring. Credit: NIAID

Tenofovir vaginal ring protects monkeys on Depo-Provera against HIV-like virus

James Smith, from US Centers for Disease Control and Prevention, presenting at ICAAC 2013.

Raltegravir appears safe for mothers and babies during pregnancy

Vincen Jeantils speaking at ICAAC 2013.

Intravenous AZT does not provide extra protection against vertical transmission in mothers with undetectable viral load

Opportunities being missed for a vaginal delivery for HIV-positive pregnant women in Europe with viral suppression